Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: An in silico molecular modeling approach in battling the COVID-19 outbreak
Background At present, the entire world is in a war against COVID-19 pandemic which has
gradually led us toward a more compromised “new normal” life. SARS-CoV-2, the …
gradually led us toward a more compromised “new normal” life. SARS-CoV-2, the …
Structural modelling and in silico pharmacology of β-carboline alkaloids as potent 5-HT1A receptor antagonists and reuptake inhibitors
Abstract Serotonin (5-HT) antagonists and reuptake inhibitors (SARIs) are atypical
antidepressants for managing major depressive disorder. They are oftentimes applied as …
antidepressants for managing major depressive disorder. They are oftentimes applied as …
QSAR, docking and pharmacokinetic studies of 2, 4-diphenyl indenol [1, 2-B] pyridinol derivatives targeting breast cancer receptors
This study presents a computational approach for designing potent compounds against
breast cancer. A robust quantitative structure-activity relationship (QSAR) model, developed …
breast cancer. A robust quantitative structure-activity relationship (QSAR) model, developed …
Phytochemdb: a platform for virtual screening and computer-aided drug designing
The phytochemicals of medicinal plants are regarded as a rich source of diverse chemical
spaces that have been used as supplements and alternative medicines in the millennium …
spaces that have been used as supplements and alternative medicines in the millennium …
[HTML][HTML] New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties
BRAF is a protein kinase that plays a vital role in MAPK signaling pathways. V600E-BRAF is
the most well-known mutation in BRAF; it was found in 8% of all the cancers, such as …
the most well-known mutation in BRAF; it was found in 8% of all the cancers, such as …
In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach
Abstract Background Hepatitis C virus (HCV) is a contagious disease that damages the liver
over time, eventually leading to cirrhosis and death. Chronic HCV infection is regarded as a …
over time, eventually leading to cirrhosis and death. Chronic HCV infection is regarded as a …
Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
Abstract Background Hepatitis C virus (HCV) is considered a worldwide health problem
since it affects over 3% of the population and causes 300,000 fatalities per year. Chronic …
since it affects over 3% of the population and causes 300,000 fatalities per year. Chronic …
Exploring compound suitability and employing DFT calculations, molecular docking, and dynamics simulation to investigate potent compounds from podophyllum …
S Mande, L Repudi, S Goswami, PK Nallasivan… - Bulletin of the National …, 2024 - Springer
Background Breast cancer, one of the most often diagnosed malignancies worldwide,
continues to take countless women's lives. Its treatment usually involves targeting the human …
continues to take countless women's lives. Its treatment usually involves targeting the human …
Cheminformatics study of some indole compounds through QSAR modeling, ADME prediction, molecular docking, and molecular dynamic simulation to identify novel …
The hepatitis C virus is a viral disease that causes cirrhosis and hepatocellular carcinoma in
the liver. Since the virus's discovery, significant therapeutic advances have been made …
the liver. Since the virus's discovery, significant therapeutic advances have been made …
In silico design, drug-likeness and ADMET properties estimation of some substituted thienopyrimidines as HCV NS3/4A protease inhibitors
In this study, we established a QSAR model for studying the antiviral activity of substituted
thienopyrimidines derivatives as HCV NS3/4A protease inhibitors. We engaged in random …
thienopyrimidines derivatives as HCV NS3/4A protease inhibitors. We engaged in random …